Major events with Dendreon have usually resulted in a significant effect on Prima.
Same old. However we all know the fundamentals for Prima are essentially unchanged.
What has changed is that it is now starkly clear that Prima, as a biotech in research phase, is a high risk speccy.
Many here, and I suspect elsewhere, had forgotten that. I've been criticised in the past on this forum for pointing that out and warning people to "don't bet the farm" on it.
I still have a lot of confidence in the future of Prima and Cvac. That's why I increased my holding by 50% yesterday.
As sure as night follows day, along the way to Phase III results, there will be a continuing roller coaster ride. It goes with the territory.
estimates required, page-3
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.010(2.50%) |
Mkt cap ! $559.2M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.5¢ | 38.5¢ | $561.9K | 1.436M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 108152 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 58690 | 17 |
View Market Depth
| Last trade - 11.35am 04/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |